抑制性受体和NK细胞上的检查点:对癌症免疫疗法的影响
Lingfei Li1, Ang Li2, Hai Jin3
1State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
Pathology, research and practice
|December 2, 2023
概括
自然杀手 (NK) 细胞和T细胞是关键的免疫力量. 向NK细胞受体为瘤治疗提供了一个有前途的策略,解决目前治疗方法的局限性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症治疗 癌症治疗
背景情况:
- 免疫抑制检查点抑制剂在癌症治疗中取得了成功.
- 不良反应和耐药性是当前瘤治疗中的重大挑战.
- T细胞和自然杀手 (NK) 细胞是抗瘤免疫反应的关键组成部分.
研究的目的:
- 审查NK细胞在各种瘤类型中的功能.
- 检查NK细胞表面受体在瘤免疫中的作用.
- 为癌症治疗确定NK细胞的潜在治疗点.
主要方法:
- 关于癌症NK细胞功能和受体研究的文献综述.
- 分析NK细胞受体调节对抗瘤免疫力的影响.
- 对针对免疫检查点的当前治疗策略的评估.
主要成果:
- 在各种癌症中观察到NK细胞活性的失调.
- 激活和抑制的NK细胞表面受体在免疫监测中起着至关重要的作用.
- 向特定的NK细胞受体在临床前和临床研究中显示出治疗潜力.
- T细胞检查点研究面临局限性,突出了需要替代策略的需要.
结论:
- NK细胞是新型癌症免疫疗法的一个有希望的目标.
- 了解NK细胞受体动态对于开发有效的癌症治疗是必不可少的.
- 准NK细胞检查点可以克服与T细胞聚焦疗法观察到的抵抗机制.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
Cells of the Innate Immune Response
1.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.7K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Immune Surveillance by NK Cells and Phagocytes
1.4K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.4K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
168
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
168


